Free
Black friday sale icon
Ready for Black Friday?
Click to generate a QR code for easy access to the app on the App Store

Details about DIRE

  • Released
  • Updated
  • iOS Version
  • Age Rating
  • Size
  • Devices
  • Languages

Features

Developer of DIRE

DIRE screenshot #1 for iPhone
iphone
ipad
🙌1
Ratings
🗣❌ unsupported
Your locale
🖼️Download
Icons↘︎

Version History of DIRE

1.2

March 31, 2022

Updates for iOS 15 Thank you for supporting DIRE!

More

1.1

February 24, 2017

This app has been updated by Apple to display the Apple Watch app icon. Added a confirmation screen to initial Terms and Conditions

More

1.0

January 17, 2017

Price History of DIRE

Description of DIRE

The DIRE Score is a tool that can be used to aid clinicians in their decision-making process when considering prescribing opioids for chronic non-malignant pain. Using the DIRE Score, the clinician rates seven factors each on a scale of 1, 2 or 3 with 1 being the least favorable or highest risk for prescribing opioids and 3 being the most compelling or lowest risk for prescribing. The seven DIRE factors are: Diagnosis, Intractability, Risk (there are four risk factors—psychological and chemical health, patient reliability and social support/life roles) and Efficacy. Adding the scores for these seven factors gives a total of 7 – 21. A score of 7-13 was predictive of a low probability of success when prescribing opioids; whereas a score of 14-21 was more likely to be associated with a successful prescribing process and outcome. The DIRE Score does not take into account medical risk factors for opioid prescribing such as comorbid medical conditions (chronic obstructive lung disease, sleep apnea, concomitant use of benzodiazepines, etc.). The clinician should understand that active use of illicit drugs, drug diversion and other aberrant behaviors is incompatible with ongoing opioid prescribing no matter what the DIRE Score may be. The DIRE Score is not meant to be a substitute for sound clinical judgment in the context of any individual patient. This App is meant for informational use only, and is not intended to aid in the diagnosis, treatment or prevention of disease. Decisions about prescribing are solely the responsibility of the licensed prescriber.
Show less

DIRE: FAQ

Is DIRE compatible with the iPad?

Yes, you can use the DIRE app on iPad devices.

Who created DIRE?

The DIRE app was created by Riemenrade Studios LLC.

What is the minimum iOS version to run the DIRE app?

Currently, DIRE supports iOS 12.0 or later.

What is the overall rating of the DIRE app?

The overall user rating of DIRE is 5.

What category is the DIRE app?

The App Genre Of The Dire App Is Medical.

What is the latest version of DIRE?

The latest DIRE version released is 1.2.

What date did the latest update for DIRE come out?

The date of the latest DIRE update is November 30, 2024.

What date did DIRE come out?

DIRE became publicly available on February 5, 2023.

What age is DIRE appropriate for?

The content advisory rating for DIRE is Riemenrade Studios LLC.

What are the languages available on DIRE?

DIRE is now available to use in English.

Is DIRE part of the Apple Arcade lineup of games?

Sorry, DIRE is not part of Apple Arcade.

Is DIRE eligible for in-app purchases?

No, DIRE is not eligible for in-app purchases.

Is DIRE fully compatible with Apple Vision Pro?

Unfortunately, DIRE is not fully compatible with Apple Vision Pro.

Does DIRE use ad-based monetization?

No, DIRE does not use ad-based monetization.

Alternatives to DIRE

Reviews of DIRE

Simple and to the point

Great app. Very useful .

Great tool

This is a great app. It's easy to use and intuitive. Really helps as a guideline when considering opioids. And it's the only tool that isn't a a self report questionnaire filled out by patients, so the kind of bias in that sort of tool just isn't there.

Easy to use opioid screening tool!

I have used the DIRE Score and taught about it for years. This app makes it simple, intuitive and lightening fast to calculate a score for patients you know. It is as handy as your phone. I love the red yellow and green buttons that, like traffic signals, guide the clinicians' go no-go decision about long-term prescribing.
Show less